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Accepted 13 June 2011A 23-year-old, gravida 3, para 1, woman underwent
amniocentesis at 20 weeks of gestation because of a previous
child affected with microvillus inclusion disease (MVID). The
child died of intractable diarrhea, sepsis, malnutrition, and
multiple organ failure at the age of 6 months. Mutation analysis
of the family revealed a c.445C>T nonsense mutation in Exon 4
of the MYO5B gene in the affected child and the father and
a c.1021C>T nonsense mutation in Exon 9 of theMYO5B gene
in the child and the mother [1]. During this pregnancy, routine
sonographic findings were normal. There was neither intestinal
dilation nor polyhydramnios. The pregnancy was uneventful
and did not have antepartum hemorrhage. Amniocentesis
revealed a karyotype of 46,XX. The level of amniotic fluid a-
fetoprotein (AFAFP) at 20 weeks of gestation was 67,420 ng/
mL (7.69 multiples of the median). Molecular analysis of the
MYO5B gene using both uncultured and cultured amniocytes
revealed compound heterozygous nonsense mutations in the
MYO5B gene. The mutation of c.445C>T or CAG>TAG
predicts a p.Q149X, and the mutation of c.1021C>T or
CAG>TAG predicts a p.Q341X in the affected fetus (Fig. 1).
The maternal serum AFP level at 23 weeks of gestation was not
elevated. The parent elected to terminate the pregnancy, and
a 634-g affected fetus was delivered at 23 weeks of gestation.
The fetus did not have structural abnormalities. The placenta
was grossly normal. Postnatal analysis of the fetal tissues
confirmed the prenatal diagnosis.* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
E-mail address: cpc_mmh@yahoo.com (C.-P. Chen).
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doi:10.1016/j.tjog.2011.06.001MVID (OMIM 251850) is an autosomal recessive disorder
of intestinal epithelial cells and is characterized by intractable
life-threatening watery diarrhea during infancy. MVID is
caused by mutations in the MYO5B gene (OMIM 606540) [2].
MYO5B encodes myosin Vb or the unconventional class V
dimeric nonfilamentous myosin that regulates membrane traf-
ficking along the recycling pathway in polarized epithelial cells
[2,3]. Loss-of-function mutations of the MYO5B gene that
cause disruption of epithelial cell polarity are a major cause of
MVID [2,4,5].MYO5Bmutations have been shown to correlate
with an aberrant subcellular distribution of the myosin Vb
protein and apical recycling endosomes [6]. The present case
had compound heterozygous nonsense mutations in the
MYO5B gene causing early truncation of MYO5B and the loss
of its function.
The present case is the first report of prenatal molecular
diagnosis of MVID. The present case did not present poly-
hydramnios and bowel dilation in the second trimester. Ruem-
mele et al [7] suggested that in cases of MVID, the pregnancy is
uneventful, and there is no polyhydramnios. However, Kennea
et al [8] and Chen et al [1] reported polyhydramnios and bowel
dilation associated with MVID in the third trimester. The
peculiar aspect of this presentation is elevated AFAFP in the
second trimester, which has not been previously described in
pregnancy with MVID. Elevated AFAFP can be associated with
fetal anomalies such as ventral wall defects, esophageal atresia,
fetal teratoma, cloacal extrophy, and epidermolysis bullosa as
well as placental abruption and hemorrhage. Because there were
no other uteroplacental and fetal factors of elevated AFAFP in
this case, we speculate that the AFAFP elevation may possibly
be caused by in utero body fluid leakage into the amniotic fluid
through fetal enteropathy.cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Compound heterozygous nonsense mutation of c.445C>T, p.Q149X in Exon 4 and c.1021C>T, p.Q341X in Eexon 9 of the MYO5B gene in the fetus.
MYO5B-01¼ fetus; WT¼wild type as control.
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